The tail end of 2020 has started to show signs of a potential end to the uncertainty and fear beset by the coronavirus pandemic. Most notably are upbeat FDA documents and early-stage Pfizer/BioNTech’s COVID-19 vaccine mass inoculations in the United Kingdom and authorization in Canada, upbeat peer studies on AstraZeneca-Oxford University vaccine results, and numerous other biotechnology firms in late-stage clinical trials.
Recently, Ed Yardeni discussed his view of why another “Roaring 20’s” may lie ahead. However, while I certainly can appreciate his always “bullish optimism,” there is a significant fundamental problem with his view.
In the midst of the Holiday season, our normal glee and excitement appear blistered. As the flu season approaches, the coronavirus pandemic has raged on, with cases steadily increasing since September. The new degree of normalcy seems to be settling into a constant or never-ending cloud of uncertainty.
In the midst of the Holiday season, our normal glee and excitement appear blistered. As the flu season approaches, the coronavirus pandemic has raged on, with cases steadily increasing since September. The new degree of normalcy seems to be settling into a constant or never-ending cloud of uncertainty.
As we enter November, investors have used newfound clarity surrounding the U.S political landscape after a contentious presidential election, with an apparent winner in Joe Biden, as a reason to forget a mostly miserable October.
This post will demonstrate Tesla’s exposures to 18 MacroRisk factors (i.e., economic factors) via the Eta® profile on the MacroRisk Analytics® platform as of November 13, 2020. Understanding these exposures can help financial advisors and investors identify potential economic risks the company is exposed to and invest accordingly. Since the information presented herein uses proprietary and patented analysis, a unique look at Tesla is provided unlike many other posts about Tesla.
The HANDLS Indexes Monthly Income Report for May 2025 underscores notable recoveries across sectors, propelled by easing tariff and trade uncertainties.
Catalyst Funds
Rational Funds
Strategy Shares